Tb Medicine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

J&J currently has a monopoly through its primary patent on the bedaquiline compound that will expire in July 2023.

Western capeSouth africaPhumeza tisileNandita venkatesanMumbai patent officeSans frontiDoctors without bordersPrime minister modiTb medicine